Daniel D Burgess insider trades

Open-market stock purchases and sales by Daniel D Burgess, Director at Cidara Therapeutics, Inc, from SEC Form 4 filings since Jun 10, 2010.

Recent trades

DateStockTradeValue
Jan 7, 2026CDTX Cidara Therapeutics, IncSold (not open market)$33.6K
Jan 7, 2026CDTX Cidara Therapeutics, IncSold (not open market)$26.9K
Jan 7, 2026CDTX Cidara Therapeutics, IncSold (not open market)$468K
Jan 7, 2026CDTX Cidara Therapeutics, IncSold (not open market)$237K
Jan 7, 2026CDTX Cidara Therapeutics, IncSold (not open market)$14.8K
Jan 7, 2026CDTX Cidara Therapeutics, IncSold (not open market)$33.2K
Jan 7, 2026CDTX Cidara Therapeutics, IncSold (not open market)$92K
Jan 7, 2026CDTX Cidara Therapeutics, IncSold (not open market)$17.6K

Companies traded

  • CDTX Cidara Therapeutics, Inc: 1 buy, last Jan 7, 2026
  • ABUS Arbutus Biopharma Corp: other filings, last May 23, 2024
  • NBRV Nabriva Therapeutics plc: 1 buy, 2 sales, last Aug 2, 2022
  • SNTS Santarus Inc: 5 sales, last Jan 2, 2014

Get free alerts when Daniel D Burgess files a new trade →